CCI clears merger of nine pharma entities with Sequent Scientific

The Competition Commission of India has approved the amalgamation of nine entities into Sequent Scientific Ltd (SSL), enhancing its position in the animal and human healthcare sectors. Furthermore, CCI has cleared the acquisition of AI Lenarco Midco by Majesty II Pte Ltd, including investments in Manjushree Technopack, thereby strengthening the involved parties' market presence.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Km7Xanp
via IFTTT